COLLABORATION

Collaboration is central to the AMELIE project. Consortium members are working closely with a range of external partners to maximise the dissemination, impact and future exploitation of the project’s research and findings.

Charities and the Third Sector

Bowel Research UK has coordinated engagement with incontinence charities across Europe to raise awareness of the implantable cell–microcarrier therapy, promote the clinical study to support participant recruitment, and share information about the project with the wider public.

Patients and the Public

People living with the condition and the wider public provide invaluable insight into its impact on everyday life. Meaningful engagement goes beyond sharing information about the research; it also creates opportunities for two-way dialogue, ensuring that patient perspectives help inform the development of new treatments.
Led by Bowel Research UK, patient and public involvement has played an important role in shaping the development of the implantable cell–microcarrier therapy by providing feedback and perspectives throughout the project.

Healthcare Professionals

Engagement with clinicians and allied health professionals across Europe has been integral to the AMELIE project. Their expertise has helped shape the research programme, supported the pathway to clinical translation, and strengthened the potential for widespread adoption of the implantable cell–microcarrier therapy in clinical practice.

Business and Industry

The AMELIE project’s external partners provide an important route for early and ongoing engagement with business and industry. The consortium is also building on established relationships with manufacturers to support the future development of the technology.
Working closely with industry will help identify and address the challenges associated with commercialising the implantable cell–microcarrier therapy, while creating opportunities for its further translational development for faecal incontinence and other potential clinical applications.